Pramipeksol (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pramipeksol" in Serbian language version.

refsWebsite
Global rank Serbian rank
4th place
8th place
2nd place
4th place
low place
low place

doi.org

  • DeBattista C, Solvason HB, Breen JA, Schatzberg AF (2000). „Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.”. J Clin Psychopharmacol. 20 (2): 274—275. PMID 10770475. doi:10.1097/00004714-200004000-00029. 
  • Zarate CA; Payne JL; Singh J; et al. (2004). „Pramipexole for bipolar II depression: a placebo-controlled proof of concept study”. Biol. Psychiatry. 56 (1): 54—60. PMID 15219473. doi:10.1016/j.biopsych.2004.03.013. 
  • Lattanzi L, Dell'Osso L, Cassano P, Pini S, Rucci P, Houck PR, Gemignani A, Battistini G, Bassi A, Abelli M, Cassano GB (2002). „Pramipexole in treatment-resistant depression: a 16-week naturalistic study.”. Bipolar Disord. 4 (5): 307—314. PMID 12479663. doi:10.1034/j.1399-5618.2002.01171.x. 
  • Cassano P, Lattanzi L, Soldani F, Navari S, Battistini G, Gemignani A, Cassano GB (2004). „Pramipexole in treatment-resistant depression: an extended follow-up.”. Depression and Anxiety. 20 (3): 131—138. PMID 15549689. doi:10.1002/da.20038. 
  • Holman AJ, Myers RR (2005). „A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.”. Arthritis Rheum. 52 (8): 2495—2505. PMID 16052595. doi:10.1002/art.21191. 
  • Schneider Claus; Mierau Joachim (1987). „Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analog of apomorphine”. Journal of Medicinal Chemistry. 30 (3): 494—8. PMID 3820220. doi:10.1021/jm00386a009. 

nih.gov

ncbi.nlm.nih.gov

  • DeBattista C, Solvason HB, Breen JA, Schatzberg AF (2000). „Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.”. J Clin Psychopharmacol. 20 (2): 274—275. PMID 10770475. doi:10.1097/00004714-200004000-00029. 
  • Zarate CA; Payne JL; Singh J; et al. (2004). „Pramipexole for bipolar II depression: a placebo-controlled proof of concept study”. Biol. Psychiatry. 56 (1): 54—60. PMID 15219473. doi:10.1016/j.biopsych.2004.03.013. 
  • Lattanzi L, Dell'Osso L, Cassano P, Pini S, Rucci P, Houck PR, Gemignani A, Battistini G, Bassi A, Abelli M, Cassano GB (2002). „Pramipexole in treatment-resistant depression: a 16-week naturalistic study.”. Bipolar Disord. 4 (5): 307—314. PMID 12479663. doi:10.1034/j.1399-5618.2002.01171.x. 
  • Cassano P, Lattanzi L, Soldani F, Navari S, Battistini G, Gemignani A, Cassano GB (2004). „Pramipexole in treatment-resistant depression: an extended follow-up.”. Depression and Anxiety. 20 (3): 131—138. PMID 15549689. doi:10.1002/da.20038. 
  • Holman AJ, Myers RR (2005). „A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.”. Arthritis Rheum. 52 (8): 2495—2505. PMID 16052595. doi:10.1002/art.21191. 
  • Schneider Claus; Mierau Joachim (1987). „Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analog of apomorphine”. Journal of Medicinal Chemistry. 30 (3): 494—8. PMID 3820220. doi:10.1021/jm00386a009. 

nps.org.au